BiotechTube
Home/InMed Pharmaceuticals/Alexandra D.J. Mancini
AD

Alexandra D.J. Mancini

SVP, Clinical and Regulatory Affairs

InMed Pharmaceuticals

Therapeutic Areas

DermatologyOphthalmologyRare Diseases

InMed Pharmaceuticals Pipeline

DrugIndicationPhase
INM-755Epidermolysis BullosaPhase 2
INM-088GlaucomaPreclinical

Leadership Team at InMed Pharmaceuticals

EA
Eric A. Adams
President, CEO & Director
BC
Bruce Colwill
Chief Financial Officer
EH
Eric Hsu
SVP, Preclinical Research and Development
View full InMed Pharmaceuticals profile